Add Company
Join Now

Convelo Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Convelo Therapeutics's estimated annual revenue is currently $3.4M per year.(i)
  • Convelo Therapeutics's estimated revenue per employee is $341,000

Employee Data

  • Convelo Therapeutics has 10 Employees.(i)
  • Convelo Therapeutics grew their employee count by -44% last year.

Convelo Therapeutics's People

NameTitleEmail/Phone
1
Head External Research and DevelopmentReveal Email/Phone
2
VP ResearchReveal Email/Phone
3
VP Business DevelopmentReveal Email/Phone
4
Director DiscoveryReveal Email/Phone
5
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M3-25%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M40%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M3636%N/AN/A
#6
$1.7M1011%N/AN/A
#7
$0.8M13225%N/AN/A
#8
$7.4M37-5%N/AN/A
#9
$0.6M30%N/AN/A
#10
$0.9M10-9%N/AN/A
Add Company

What Is Convelo Therapeutics?

Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimer’s. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$3.4M

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M1043%N/A
#2
$0.9M1011%N/A
#3
$0.9M10-9%N/A
#4
$0.7M1011%N/A
#5
$2.4M10-9%N/A